Drug search by name

Novaplus Irinotecan Hydrochloride and Interstitial lung disease

Result of checking the interaction of drug Novaplus Irinotecan Hydrochloride and disease Interstitial lung disease for safety when used together.

Check result:

Novaplus Irinotecan Hydrochloride <> Interstitial lung disease

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Irinotecan can cause severe and fatal interstitial pulmonary disease (IPD). Risk factors include preexisting-existing lung disease. It is recommended to withhold treatment with irinotecan in patients with new or progressive dyspnea, cough, and fever, pending diagnostic evaluation and to discontinue treatment in patients with a confirmed diagnosis of IPD. Exercise caution when using this agent in patients presenting symptoms of dyspnea and patients with pulmonary impairment.

Novaplus Irinotecan Hydrochloride

Generic Name: irinotecan

Brand Name: Camptosar

Synonyms: Irinotecan, Irinotecan (Conventional)

What is Novaplus Irinotecan Hydrochloride?